Cuayzon, Jhonas V.
HRN: 20-24-53 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/08/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/08/2022
06/14/2022
IV
4.5g
Q6hours
MDR TB
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes